Update on the pathophysiology and classification of von Willebrand disease
The molecular basis of quantitative fibrinogen disorders
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? Yes
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No
Unveiling the inflammatory face of antiplatelet drugs
Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease
New light on an old story
von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen
When it comes to von Willebrand disease, does 1 + 1 = 3?
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease
Hemophilia and immunology at the crossroads
Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain
Family secrets to be disclosed
Family history and inherited thrombophilia
Thrombin is bad, accepted; but is smoking good to prevent restenosis?
Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow-derived progenitor cells expressing membrane-tethered anticoagulant fusion proteins
Hormonal factors and risk of recurrent venous thrombosis
Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease
A re-appraisal of the normal cut-off assignment for anticardiolipin IgM tests
Plasma contains protein S monomers and multimers with similar direct anticoagulant activity
Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIII
Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo
Thrombin induces GPIb-IX-mediated fibrin binding to αIIbβ3 in a reconstituted Chinese hamster ovary cell model
Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells
Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells
Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart disease
Proposal to establish a European Association for Hemophilia and Allied Disorders
The international immune tolerance study
Body mass index and the risk of venous thrombosis among postmenopausal women
Clinical relevance of the recent update of the classification criteria for definite antiphospholipid syndrome
Identification of critical residues for regulation of integrin activation in the β6–α7 loop of the integrin β3 I-like domain
Therapeutic range for unfractionated heparin therapy
Plasma levels of the growth arrest-specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjects
Functional analysis of two prothrombin 3′-untranslated region variants
More on
More on